Cargando…
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627394/ https://www.ncbi.nlm.nih.gov/pubmed/34824121 http://dx.doi.org/10.1136/bmjopen-2021-054160 |
_version_ | 1784606846006329344 |
---|---|
author | Millgate, Edward Kravariti, Eugenia Egerton, Alice Howes, Oliver D Murray, Robin M Kassoumeri, Laura Donocik, Jacek Lewis, Shôn Drake, Richard Lawrie, Stephen Murphy, Anna Collier, Tracy Lees, Jane Stockton-Powdrell, Charlotte Walters, James Deakin, Bill MacCabe, James |
author_facet | Millgate, Edward Kravariti, Eugenia Egerton, Alice Howes, Oliver D Murray, Robin M Kassoumeri, Laura Donocik, Jacek Lewis, Shôn Drake, Richard Lawrie, Stephen Murphy, Anna Collier, Tracy Lees, Jane Stockton-Powdrell, Charlotte Walters, James Deakin, Bill MacCabe, James |
author_sort | Millgate, Edward |
collection | PubMed |
description | BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language functions may be more impaired in treatment resistance. We sought to confirm this finding by comparing cognitive performance between antipsychotic non-responders (NR) and responders (R) using a brief cognitive battery for schizophrenia, with a primary focus on verbal tasks compared against other measures of cognition. DESIGN: Cross-sectional. SETTING: This cross-sectional study recruited antipsychotic treatment R and antipsychotic NR across four UK sites. Cognitive performance was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS). PARTICIPANTS: One hundred and six participants aged 18–65 years with a diagnosis of schizophrenia or schizophreniform disorder were recruited according to their treatment response, with 52 NR and 54 R cases. OUTCOMES: Composite and subscale scores of cognitive performance on the BACS. Group (R vs NR) differences in cognitive scores were investigated using univariable and multivariable linear regressions adjusted for age, gender and illness duration. RESULTS: Univariable regression models observed no significant differences between R and NR groups on any measure of the BACS, including verbal memory (ß=−1.99, 95% CI −6.63 to 2.66, p=0.398) and verbal fluency (ß=1.23, 95% CI −2.46 to 4.91, p=0.510). This pattern of findings was consistent in multivariable models. CONCLUSIONS: The lack of group difference in cognition in our sample is likely due to a lack of clinical distinction between our groups. Future investigations should aim to use machine learning methods using longitudinal first episode samples to identify responder subtypes within schizophrenia, and how cognitive factors may interact within this. TRAIL REGISTRATION NUMBER: REC: 15/LO/0038. |
format | Online Article Text |
id | pubmed-8627394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-86273942021-12-10 Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study Millgate, Edward Kravariti, Eugenia Egerton, Alice Howes, Oliver D Murray, Robin M Kassoumeri, Laura Donocik, Jacek Lewis, Shôn Drake, Richard Lawrie, Stephen Murphy, Anna Collier, Tracy Lees, Jane Stockton-Powdrell, Charlotte Walters, James Deakin, Bill MacCabe, James BMJ Open Mental Health BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language functions may be more impaired in treatment resistance. We sought to confirm this finding by comparing cognitive performance between antipsychotic non-responders (NR) and responders (R) using a brief cognitive battery for schizophrenia, with a primary focus on verbal tasks compared against other measures of cognition. DESIGN: Cross-sectional. SETTING: This cross-sectional study recruited antipsychotic treatment R and antipsychotic NR across four UK sites. Cognitive performance was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS). PARTICIPANTS: One hundred and six participants aged 18–65 years with a diagnosis of schizophrenia or schizophreniform disorder were recruited according to their treatment response, with 52 NR and 54 R cases. OUTCOMES: Composite and subscale scores of cognitive performance on the BACS. Group (R vs NR) differences in cognitive scores were investigated using univariable and multivariable linear regressions adjusted for age, gender and illness duration. RESULTS: Univariable regression models observed no significant differences between R and NR groups on any measure of the BACS, including verbal memory (ß=−1.99, 95% CI −6.63 to 2.66, p=0.398) and verbal fluency (ß=1.23, 95% CI −2.46 to 4.91, p=0.510). This pattern of findings was consistent in multivariable models. CONCLUSIONS: The lack of group difference in cognition in our sample is likely due to a lack of clinical distinction between our groups. Future investigations should aim to use machine learning methods using longitudinal first episode samples to identify responder subtypes within schizophrenia, and how cognitive factors may interact within this. TRAIL REGISTRATION NUMBER: REC: 15/LO/0038. BMJ Publishing Group 2021-11-25 /pmc/articles/PMC8627394/ /pubmed/34824121 http://dx.doi.org/10.1136/bmjopen-2021-054160 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Mental Health Millgate, Edward Kravariti, Eugenia Egerton, Alice Howes, Oliver D Murray, Robin M Kassoumeri, Laura Donocik, Jacek Lewis, Shôn Drake, Richard Lawrie, Stephen Murphy, Anna Collier, Tracy Lees, Jane Stockton-Powdrell, Charlotte Walters, James Deakin, Bill MacCabe, James Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title | Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title_full | Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title_fullStr | Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title_full_unstemmed | Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title_short | Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study |
title_sort | cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the strata study |
topic | Mental Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627394/ https://www.ncbi.nlm.nih.gov/pubmed/34824121 http://dx.doi.org/10.1136/bmjopen-2021-054160 |
work_keys_str_mv | AT millgateedward crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT kravaritieugenia crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT egertonalice crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT howesoliverd crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT murrayrobinm crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT kassoumerilaura crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT donocikjacek crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT lewisshon crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT drakerichard crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT lawriestephen crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT murphyanna crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT colliertracy crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT leesjane crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT stocktonpowdrellcharlotte crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT waltersjames crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT deakinbill crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy AT maccabejames crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy |